Julie L. Gerberding - Feb 24, 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP, Chief Patient Officer
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Julie L. Gerberding
Stock symbol
MRK
Transactions as of
Feb 24, 2022
Transactions value $
$702,021
Form type
4
Date filed
2/28/2022, 03:17 PM
Previous filing
Nov 3, 2021
Next filing
Apr 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Award $702K +9.55K +24.39% $73.51 48.7K Feb 24, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/19. Performance shares were paid out at 140 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2021.
F2 Holdings include shares acquired in dividend reinvestment transactions.